Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SchizOMICS: Aripiprazole vs Paliperidone in First Episode Psychosis
NCT06060886Phase 4Not yet recruiting
- Sponsor
- CiberMed
- Start
- Nov 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial in psychosis comparing Aripiprazole with Paliperidone (2 arms). Primary endpoint: Number of patients with a therapeutic response at 3 months. Planned start Nov 2023; status: not yet recruiting.
02
Drugs
aripiprazolepaliperidone
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT06060886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06060886.